Decreased high-density lipoprotein cholesterol levels in polyarticular juvenile idiopathic arthritis

Clinics

Volumn 66, Issue 9, 2011, Pages 1549-1552

  Marangoni, Roberta Gonçalves ^a   Hayata, Andre L ^a   Borba, Eduardo F ^a   Azevedo, Pedro M ^a   Bonfá, Eloisa ^a   Goldenstein Schainberg, Claudia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atherosclerosis; Dyslipidemia; Juvenile; Lipids; Rheumatic disease

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD; DYSLIPIDEMIA; EPIDEMIOLOGY; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALE; SEX DIFFERENCE;

ADULT; ARTHRITIS, JUVENILE RHEUMATOID; CHOLESTEROL, HDL; DYSLIPIDEMIAS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; SEX FACTORS;

EID: 80053538870     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000900007     Document Type: Article

References (34)

1. Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz SR, Kinosian B. Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med. 2003;25:5-7 doi: 10.1016/ S0749-3797(03)00092-8.
2. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37:481-94 doi: 10.1002/art.1780370408.
3. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis. Arthritis Rheum. 2005; 52:722-32 doi: 10.1002/art.20878.
4. Kremers HM, Crowson CS, Therneau TM, Roger VL, Gabriel SE. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum. 2008;58:2268-74 doi: 10.1002/art.23650.
5. Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD. The Rationale for Comparative Studies of Accelerated atherosclerosis in Rheumatic Diseases. Curr Vasc Pharmacol. 2010;8:437-49 doi: 10.2174/157016110791330852.
6. Thomas E, Symmons DP, Brewester DH, Black RJ, Macfarlane GJ. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis and other rheumatic conditions: a 20-year follow-up study. J Rheumatol. 2003;30:958-65.
7. Del Rincon I, Escalante A. Atherosclerotic cardiovascular disease in rheumatoid arthritis. Curr Rhematol Rep. 2003;5:278-86 doi: 10.1007/ s11926-003-0006-8.
8. Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis. Arthritis Rheum. 46:862-873 doi: 10.1002/art.10089
9. Ilowite NT, Samuel P, Beseler L, Jacobson MS. Dyslipoproteinemia in juvenile rheumatoid arthritis. J Pediatrics. 1989;114:823-6 doi: 10.1016/ S0022-3476(89)80148-9.
10. Musiej-Nowakowska E, Zawadzka F, Weso3owska H, Miko3ajew M. Serum lipid concentration in juvenile rheumatoid arthritis. Acta Univ Carol. 1991;37:46-9.
11. Bakkaloglu A, Kirel B, Ozen S, Saatçi U, Topaloglu, Besbas N. Plasma lipids and lipoproteins in juvenile chronic arthritis. Clin Rheumatol. 1996;15:341-5 doi: 10.1007/BF02230355.
12. Tselepis AD, Elisaf M, Besis S, Karabina SA, Chapman MJ, Siamopoulou A. Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and deuced lipoprotein associated platelet-activating factor acetylhydrolase activity. Arthritis Rheum. 1999;42:373-83 doi: 10.1002/1529-0131(199902)42:2,373::AIDANR21.3.0. CO;2-3.
13. Pietrewicz E, Urban M. [Early atherosclerosis changes in children with juvenile idiopathic arthritis] Pol Merkur Lekarski. 2007;22:211-4 [Article in Polish].
14. Gonçalves M, D'Almeida V, Guerra-Shinohara EM, Galdieri LC, Len CA, Hilário MO. Homocysteine and lipid profile in children with Juvenile Idiopathic Arthritis. Pediatr Rheumatol Online J. 2007;5:2 doi: 10.1186/ 1546-0096-5-2.
15. Thomas E, Barret JH, Donn RP, Thomson W, Southwood TR. Subtyping of juvenile idiopathic arthritis using latent class analysis. British Paediatric Rheumatology Group. Arthritis Rheum. 2000;43:1496-503.
16. Libby P, Ridker PM, Maseri A. Inflammation and Atherosclerosis. Circulation. 2002;105:1135-43 doi: 10.1161/hc0902.104353.
17. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390-2.
18. Siedel J, Hägele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clinical Chemistry. 1983;29:1075-80.
19. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical Chemistry. 1982;28:2077-80.
20. Warnick GR, Cheung MC, Albers JJ. Comparison of current methods for high-density lipoprotein cholesterol quantitation. Clinical Chemistry. 1979;25:596-604.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 1972;18:499-502.
22. Sposito AC, Caramelli B, Fonseca FA, Bertolami MC, Afiune Neto A, Souza AD, et al. IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology. Arq Bras Cardiol. 2007;88(Suppl. I):2-19 doi: 10. 1590/S0066-782X2007000700002.
23. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
24. American Academy of PEDIATRICS. National Cholesterol Education Program (NCEP): report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics. 1992;89:525-84.
25. Parnell LD, Lee YC, Lai CQ. Adaptive genetic variation and heart disease risk. Curr Opin Lipidol. 2010;21:116-22 doi: 10.1097/MOL.0b013e328 3378e42.
26. Chandalia M, Mohan V, Adams-Huet B, Deepa R, Abate N. Ethnic difference in sex gap in high-density lipoprotein cholesterol between Asian Indians and Whites. J Investig Med. 2008;56:574-80.
27. Hahn BH, Grossman J, Ansell BJ, Skaggs BJ, McMahon M. Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther. 2008;10:213 doi: 10.1186/ar2471.
28. Svenungsson E, Gunnarsson I, Fei GZ, Lundberg IE, Klareskog L, Frostega°rd J. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with upregulation of tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis Rheum. 2003;48:2533- 40 doi: 10.1002/art.11264.
29. Borba EF, Bonfá E. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus. 1997;6:533-9 doi: 10.1177/096120339700600610.
30. Hayata AL, Borba EF, Bonfá E, Kochen JA, Goldenstein-Schainberg C. The frequency of high/moderate lipoprotein risk factor for coronary artery disease is significant in juvenile-onset systemic lupus erythematosus. Lupus. 2005;14:613-7 doi: 10.1191/0961203305lu2177oa.
31. Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol. 2002;29:1989-99.
32. Volkmann ER, Grossman JM, Sahakian LJ, Skaggs BJ, FitzGerald J, Ragavendra N, et al. Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010;62:258-65 doi: 10.1002/acr.20076.
33. Borba EF, Bonfá E. Long-term beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy. J Rheumatol. 2001;28:780-5.
34. Ettinger WH, Klinefelter HF, Kwiterovich PO. Effects of short term, low dose corticosteroids on plasma lipoprotein lipids. Atherosclerosis. 1987;63:167-72 doi: 10.1016/0021-9150(87)90117-1.